1. Product Overview
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2. Research Methodology
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and
Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation &
Validation
2.7. Assumptions and Limitations
3. Executive Summary
3.1. Overview of the Market
3.2. Overview of Key Market
Segmentations
3.3. Overview of Key Market
Players
3.4. Overview of Key
Regions/Countries
3.5. Overview of Market Drivers,
Challenges, and Trends
4. Voice of Customer
5. Global Premenstrual
Syndrome (PMS) and Menstrual Health Supplements Market Outlook
5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By Product Type (Combined Nutritional Supplements, Single
Nutritional Supplements)
5.2.2. By Indication
(Perimenopause, PMS)
5.2.3. By Formulation
(Capsules/Tablets, Powder, Softgels, Other)
5.2.4. By End Use (Pharmacies/Drug
Stores, Online Sales Channel, Direct Sales Channel, Others)
5.2.5. By Company (2024)
5.2.6. By Region
5.3. Market Map
6. North America Premenstrual
Syndrome (PMS) and Menstrual Health Supplements Market Outlook
6.1. Market Size &
Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Product Type
6.2.2. By Indication
6.2.3. By Formulation
6.2.4. By End Use
6.2.5. By Country
6.3. North America: Country
Analysis
6.3.1. United States Premenstrual
Syndrome (PMS) and Menstrual Health Supplements Market Outlook
6.3.1.1. Market Size & Forecast
6.3.1.1.1. By Value
6.3.1.2. Market Share & Forecast
6.3.1.2.1. By Product Type
6.3.1.2.2. By Indication
6.3.1.2.3. By Formulation
6.3.1.2.4. By End Use
6.3.2. Mexico Premenstrual
Syndrome (PMS) and Menstrual Health Supplements Market Outlook
6.3.2.1. Market Size & Forecast
6.3.2.1.1. By Value
6.3.2.2. Market Share & Forecast
6.3.2.2.1. By Product Type
6.3.2.2.2. By Indication
6.3.2.2.3. By Formulation
6.3.2.2.4. By End Use
6.3.3. Canada Premenstrual
Syndrome (PMS) and Menstrual Health Supplements Market Outlook
6.3.3.1. Market Size & Forecast
6.3.3.1.1. By Value
6.3.3.2. Market Share & Forecast
6.3.3.2.1. By Product Type
6.3.3.2.2. By Indication
6.3.3.2.3. By Formulation
6.3.3.2.4. By End Use
7. Europe Premenstrual
Syndrome (PMS) and Menstrual Health Supplements Market Outlook
7.1. Market Size &
Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Product Type
7.2.2. By Indication
7.2.3. By Formulation
7.2.4. By End Use
7.2.5. By Country
7.3. Europe: Country Analysis
7.3.1. France Premenstrual
Syndrome (PMS) and Menstrual Health Supplements Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Product Type
7.3.1.2.2. By Indication
7.3.1.2.3. By Formulation
7.3.1.2.4. By End Use
7.3.2. Germany Premenstrual
Syndrome (PMS) and Menstrual Health Supplements Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Product Type
7.3.2.2.2. By Indication
7.3.2.2.3. By Formulation
7.3.2.2.4. By End Use
7.3.3. United Kingdom Premenstrual
Syndrome (PMS) and Menstrual Health Supplements Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Product Type
7.3.3.2.2. By Indication
7.3.3.2.3. By Formulation
7.3.3.2.4. By End Use
7.3.4. Italy Premenstrual Syndrome
(PMS) and Menstrual Health Supplements Market Outlook
7.3.4.1. Market Size & Forecast
7.3.4.1.1. By Value
7.3.4.2. Market Share & Forecast
7.3.4.2.1. By Product Type
7.3.4.2.2. By Indication
7.3.4.2.3. By Formulation
7.3.4.2.4. By End Use
7.3.5. Spain Premenstrual Syndrome
(PMS) and Menstrual Health Supplements Market Outlook
7.3.5.1. Market Size & Forecast
7.3.5.1.1. By Value
7.3.5.2. Market Share & Forecast
7.3.5.2.1. By Product Type
7.3.5.2.2. By Indication
7.3.5.2.3. By Formulation
7.3.5.2.4. By End Use
8. Asia-Pacific Premenstrual
Syndrome (PMS) and Menstrual Health Supplements Market Outlook
8.1. Market Size &
Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Product Type
8.2.2. By Indication
8.2.3. By Formulation
8.2.4. By End Use
8.2.5. By Country
8.3. Asia-Pacific: Country
Analysis
8.3.1. China Premenstrual Syndrome
(PMS) and Menstrual Health Supplements Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Product Type
8.3.1.2.2. By Indication
8.3.1.2.3. By Formulation
8.3.1.2.4. By End Use
8.3.2. India Premenstrual Syndrome
(PMS) and Menstrual Health Supplements Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Product Type
8.3.2.2.2. By Indication
8.3.2.2.3. By Formulation
8.3.2.2.4. By End Use
8.3.3. South Korea Premenstrual
Syndrome (PMS) and Menstrual Health Supplements Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Product Type
8.3.3.2.2. By Indication
8.3.3.2.3. By Formulation
8.3.3.2.4. By End Use
8.3.4. Japan Premenstrual Syndrome
(PMS) and Menstrual Health Supplements Market Outlook
8.3.4.1. Market Size & Forecast
8.3.4.1.1. By Value
8.3.4.2. Market Share & Forecast
8.3.4.2.1. By Product Type
8.3.4.2.2. By Indication
8.3.4.2.3. By Formulation
8.3.4.2.4. By End Use
8.3.5. Australia Premenstrual
Syndrome (PMS) and Menstrual Health Supplements Market Outlook
8.3.5.1. Market Size & Forecast
8.3.5.1.1. By Value
8.3.5.2. Market Share & Forecast
8.3.5.2.1. By Product Type
8.3.5.2.2. By Indication
8.3.5.2.3. By Formulation
8.3.5.2.4. By End Use
9. South America Premenstrual
Syndrome (PMS) and Menstrual Health Supplements Market Outlook
9.1. Market Size &
Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Product Type
9.2.2. By Indication
9.2.3. By Formulation
9.2.4. By End Use
9.2.5. By Country
9.3. South America: Country
Analysis
9.3.1. Brazil Premenstrual
Syndrome (PMS) and Menstrual Health Supplements Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Product Type
9.3.1.2.2. By Indication
9.3.1.2.3. By Formulation
9.3.1.2.4. By End Use
9.3.2. Argentina Premenstrual
Syndrome (PMS) and Menstrual Health Supplements Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Product Type
9.3.2.2.2. By Indication
9.3.2.2.3. By Formulation
9.3.2.2.4. By End Use
9.3.3. Colombia Premenstrual
Syndrome (PMS) and Menstrual Health Supplements Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Product Type
9.3.3.2.2. By Indication
9.3.3.2.3. By Formulation
9.3.3.2.4. By End Use
10. Middle East and Africa
Premenstrual Syndrome (PMS) and Menstrual Health Supplements
Market Outlook
10.1. Market Size &
Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Product Type
10.2.2. By Indication
10.2.3. By Formulation
10.2.4. By End Use
10.2.5. By Country
10.3. MEA: Country Analysis
10.3.1. South Africa Premenstrual
Syndrome (PMS) and Menstrual Health Supplements Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1. By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1. By Product Type
10.3.1.2.2. By Indication
10.3.1.2.3. By Formulation
10.3.1.2.4. By End Use
10.3.2. Saudi Arabia Premenstrual
Syndrome (PMS) and Menstrual Health Supplements Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1. By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1. By Product Type
10.3.2.2.2. By Indication
10.3.2.2.3. By Formulation
10.3.2.2.4. By End Use
10.3.3. UAE Premenstrual Syndrome
(PMS) and Menstrual Health Supplements Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1. By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1. By Product Type
10.3.3.2.2. By Indication
10.3.3.2.3. By Formulation
10.3.3.2.4. By End Use
11. Market Dynamics
11.1. Drivers
11.2. Challenges
12. Market Trends &
Developments
12.1. Merger & Acquisition
(If Any)
12.2. Product Launches (If Any)
12.3. Recent Developments
13. Porters Five Forces
Analysis
13.1. Competition in the Industry
13.2. Potential of New Entrants
13.3. Power of Suppliers
13.4. Power of Customers
13.5. Threat of Substitute
Products
14. Competitive Landscape
14.1. Herbalife International of
America, Inc.
14.1.1. Business Overview
14.1.2. Company Snapshot
14.1.3. Products & Services
14.1.4. Financials (As Reported)
14.1.5. Recent Developments
14.1.6. Key Personnel Details
14.1.7. SWOT Analysis
14.2. Nature’s Bounty
14.3. Amway Corp.
14.4. GNC Holdings, LLC
14.5. USANA Health Sciences, Inc
14.6. GlaxoSmithKline Plc
14.7. MetP Pharma AG
14.8. Archer-Daniels-Midland
Company
14.9. Power Gummies
14.10. Looni
15. Strategic Recommendations
16. About Us & Disclaimer